Skip to main content
. 2021 Oct 30;10(21):5098. doi: 10.3390/jcm10215098

Table 4.

Comparison of the clinical presentation of COVID-19 in children between the 1st and 2nd waves of the pandemic.

Clinical Factor Patients Diagnosed between March and August 2020
N = 465
Patients Diagnosed between September and December 2020
N = 818
p OR (95% CI)
Age (months)
Median (IQR)
102.0 (44.0; 154.7) 53.0 (9.0; 156.0) <0.0001 0.99 (0.99–0.99)
Sex (male/female) 223 (48)/242 (52) 427 (52)/391 (48) 0.14 -
Hospitalized 321 (69) 687 (84) <0.0001 2.29 (1.74–3.01)
Duration of hospitalization (days), median (IQR) 1 (1; 3) 3 (1; 6) <0.0001 1.07 (1.04–1.11)
Household contact with an infected family member 360 (78) 355 (43) <0.0001 0.39 (0.31–0.49)
Confirmed other contact 5 (1) 43 (5) 0.0001 -
International travel during the 14 days before symptom onset 31 (7) 12 (1) <0.0001 0.20 (0.10–0.40)
Comorbidities 70 (15) 198 (24) 0.0001 1.72 (1.27–2.31)
CLINICAL PRESENTATION
Asymptomatic disease course 167 (36) 104 (13) <0.0001 0.26 (0.19–0.34)
Pneumonia related to COVID-19 42 (9) 114 (14) 0.009 1.63 (1.12–2.38)
Gastrointestinal symptoms 58 (12) 237 (29) <0.0001 2.87 (2.10–3.94)
Fever 152 (33) 445 (54) <0.0001 2.30 (1.81–2.93)
Cough 109 (23) 308 (38) <0.0001 1.86 (1.43–2.41)
Rhinitis 79 (17) 260 (32) <0.0001 2.17 (1.63–2.89)
Weakness 68 (15) 237 (29) <0.0001 2.25 (1.66–3.03)
Diarrhea 40 (9) 151 (18) <0.0001 2.27 (1.57–3.29)
Headache 39 (8) 102 (12) 0.02 1.48 (1.01–2.19)
Sore throat 41 (9) 73 (9) 0.94 -
Anosmia 45 (10) 59 (7) 0.12 -
Vomiting 19 (4) 92 (11) <0.0001 2.74 (1.66–4.52)
Abdominal pain 18 (4) 100 (12) <0.0001 3.16 (1.91-5.25)
Loss of appetite 9 (2) 84 (10) <0.0001 6.51 (3.24-13.09)
Muscle pain 26 (6) 70 (9) 0.05 -
Dyspnea 19 (4) 57 (7) 0.03 -
Rash 20 (4) 50 (6) 0.17 -
Chest pain 13 (3) 34 (4) 0.21 -
Conjunctivitis 7 (2) 18 (2) 0.38 -
Seizures 3 (1) 21 (3) 0.01 -

Data are presented as a number (%) unless otherwise indicated. CI—confidence interval and OR—odds ratio.